CTX-4430
CTX-4430-AV-201
Phase 2 small_molecule completed
Quick answer
CTX-4430 for Acne Vulgaris is a Phase 2 program (small_molecule) at CNS Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CNS Pharmaceuticals
- Indication
- Acne Vulgaris
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed